Who are Beam Therapeutics Inc.'s main suppliers?

Beam Therapeutics Inc. (BEAM) key suppliers include: KOBE-UNIVERSITY, Eli Lilly and Company, Prime Medicine, Inc., Sana Biotechnology, Inc.. View the full supplier network at chainsifter.com/chain/BEAM.

Who are Beam Therapeutics Inc.'s major customers?

Beam Therapeutics Inc. (BEAM) key customers include: Sana Biotechnology, Inc.. View the full customer network at chainsifter.com/chain/BEAM.

What sector is Beam Therapeutics Inc. in?

Beam Therapeutics Inc. (BEAM) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

BEAM Supply Chain: Beam Therapeutics Inc. Supplier List & 7 Relationships

4Suppliers

1Customers

2Debt Items

20Related Chains

Beam Therapeutics Inc. Suppliers

Ticker	Name	Confidence	Evidence
KOBE-UNIVERSITY	KOBE-UNIVERSITY	85%	Bio Palette licensed directly from Kobe University
LLY	Eli Lilly and Company	72%	Reciprocal relationship from LLY graph: Reciprocal relationship from BEAM graph: Reciprocal relationship from LLY graph: Reciprocal relationship from BEAM graph: Reciprocal relationship from LLY grap…
PRME	Prime Medicine, Inc.	72%	Reciprocal relationship from PRME graph: Reciprocal relationship from BEAM graph: Reciprocal relationship from PRME graph: orm is expected to allow Prime Medicine to generate follow-on candidates rap…
SANA	Sana Biotechnology, Inc.	72%	Reciprocal relationship from SANA graph: the University of California (UCSF), our fusogen technology that we acquired from Cobalt Biomedicine, Inc. (Cobalt), and gene editing technology that we licen…

Beam Therapeutics Inc. Customers

Ticker	Name	Confidence	Evidence
SANA	Sana Biotechnology, Inc.	72%	Reciprocal relationship from SANA graph: the University of California (UCSF), our fusogen technology that we acquired from Cobalt Biomedicine, Inc. (Cobalt), and gene editing technology that we licen…

Beam Therapeutics Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
BEAM-DEBT-8131	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2020-12-31.
BEAM-DEBT	Debt stack $250.8M	90%	Market cache reports total debt of $250.8M.

Beam Therapeutics Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Beam Therapeutics Inc..

Beam Therapeutics Inc. Ownership

Holder	Name	Confidence	Evidence
BEAM-OWNER-FMR-LLC	FMR LLC	90%	13F overlay lists FMR LLC as top holder; 254 tracked holders.

Beam Therapeutics Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
HOWL	Werewolf Therapeutics, Inc.	100.00	2
KRRO	Korro Bio, Inc.	100.00	2
DRTS	Alpha Tau Medical Ltd.	100.00	2
WHWK	Whitehawk Therapeutics, Inc.	100.00	2
JANX	Janux Therapeutics, Inc.	100.00	2
AZN	AstraZeneca PLC	100.00	2
CTMX	CytomX Therapeutics, Inc.	100.00	2
EDIT	Editas Medicine, Inc.	100.00	1	['receiving']
EMMA	Emmaus Life Sciences, Inc.	100.00	2
SDGR	Schrödinger, Inc.	100.00	2
ANL	Adlai Nortye Ltd.	100.00	2
IBIO	iBio, Inc.	100.00	2
TLSA	Tiziana Life Sciences Ltd	100.00	2
CPMV	Mosaic ImmunoEngineering, Inc.	100.00	2
CHRS	Coherus Oncology, Inc.	100.00	2
CLLS	Cellectis S.A.	100.00	2
GRFS	Grifols, S.A.	100.00	2
BMY	Bristol-Myers Squibb Company	100.00	1	['receiving']
BMYMP	Bristol-Myers Squibb Co	100.00	1	['receiving']
KRYS	Krystal Biotech, Inc.	100.00	2

Beam Therapeutics Inc. Supply Chain